Education
About Us
Working with TipRanks
Follow Us
Tikun Olam-Cannbit Pharmaceuticals Ltd. (IL:TKUN)
:TKUN
TKUN Stock Chart & Stats
Day’s Range― - ―
52-Week Range26.60 - 47.50
Previous CloseN/A
Volume0.00
Average Volume (3M)62.74K
Market Cap
33.48M
Enterprise ValueN/A
Total Cash (Recent Filing)4.18M
Total Debt (Recent Filing)17.45M
Price to Earnings (P/E)―
Beta0.35
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Dec 28, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding84,964,516
10 Day Avg. Volume79,541
30 Day Avg. Volume62,740
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TKUN FAQ
What was Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price range in the past 12 months?
Tikun Olam-Cannbit Pharmaceuticals Ltd. lowest stock price was 26.60 and its highest was 47.50 in the past 12 months.
What is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s market cap?
Tikun Olam-Cannbit Pharmaceuticals Ltd.’s market cap is 33.48M.
When is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tikun Olam-Cannbit Pharmaceuticals Ltd.’s earnings last quarter?
Tikun Olam-Cannbit Pharmaceuticals Ltd. released its earnings results on Aug 24, 2021. The company reported -33.3 earnings per share for the quarter, missing the consensus estimate of N/A by -33.3.
Is Tikun Olam-Cannbit Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Tikun Olam-Cannbit Pharmaceuticals Ltd. pay dividends?
Tikun Olam-Cannbit Pharmaceuticals Ltd. pays a Quarterly dividend of 141.135 which represents an annual dividend yield of N/A. See more information on Tikun Olam-Cannbit Pharmaceuticals Ltd. dividends here
What is Tikun Olam-Cannbit Pharmaceuticals Ltd.’s EPS estimate?
Tikun Olam-Cannbit Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tikun Olam-Cannbit Pharmaceuticals Ltd. have?
Tikun Olam-Cannbit Pharmaceuticals Ltd. has 84,964,516 shares outstanding.
What happened to Tikun Olam-Cannbit Pharmaceuticals Ltd.’s price movement after its last earnings report?
Tikun Olam-Cannbit Pharmaceuticals Ltd. reported an EPS of -33.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tikun Olam-Cannbit Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IL:TKUN
Company Description
Tikun Olam-Cannbit Pharmaceuticals Ltd.
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.